REQUEST A DEMO
Total
USD $0.00
Search more companies

Spetzializirana Bolnitza Za Aktivno Lechenie Na Hematologichni Zaboliavania EAD (Bulgaria)

Main Activities: General Medical and Surgical Hospitals
Full name: Spetzializirana Bolnitza Za Aktivno Lechenie Na Hematologichni Zaboliavania EAD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Spetzializirana Bolnitza Za Aktivno Lechenie Na Hematologichni Zaboliavania EAD is an enterprise based in Bulgaria. Its main office is in Sofia. It operates in the General Medical and Surgical Hospitals sector. The company was established on May 07, 2008. The total number of employees is currently 214 (2023). The latest financial highlights indicate a net sales revenue increase of 13.34% in 2021. Its’ total assets recorded a negative growth of 1.81%. In, 2021, the company’s net profit margin increased by 11.38%.

Headquarters
bul. Kliment Ohridski 1A
Sofia; Sofia - city; Postal Code: 1797

Contact Details: Purchase the Spetzializirana Bolnitza Za Aktivno Lechenie Na Hematologichni Zaboliavania EAD report to view the information.

Basic Information
Total Employees:
Purchase the Spetzializirana Bolnitza Za Aktivno Lechenie Na Hematologichni Zaboliavania EAD report to view the information.
Outstanding Shares:
Purchase the Spetzializirana Bolnitza Za Aktivno Lechenie Na Hematologichni Zaboliavania EAD report to view the information.
Registered Capital:
Purchase the Spetzializirana Bolnitza Za Aktivno Lechenie Na Hematologichni Zaboliavania EAD report to view the information.
Financial Auditors:
Purchase the Spetzializirana Bolnitza Za Aktivno Lechenie Na Hematologichni Zaboliavania EAD report to view the information.
Incorporation Date:
May 07, 2008
Key Executives
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Spetzializirana Bolnitza Za Aktivno Lechenie Na Hematologichni Zaboliavania EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
13.34%
Total operating revenue
18.61%
Operating profit (EBIT)
1553.57%
EBITDA
254.38%
Net Profit (Loss) for the Period
1468.03%
Total assets
-1.81%
Total equity
44.52%
Operating Profit Margin (ROS)
11.49%
Net Profit Margin
11.38%
Return on Equity (ROE)
-69.86%
Quick Ratio
0.02%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?